Clinical and laboratory COVID-19 features in hospitalized patients with concomitant diabetes mellitus type 2: A retrospective study

Arailym Abilbayeva 1 * , Anel Tarabayeva 1, Gulzhana Idrisova 1, Aigul Abdrakhmanova 2, Ainur Sadykova 3, Ravilya Yegemberdiyeva 3, Amangul Duisenova 3
More Detail
1 Department of General Immunology, Asfendiyarov Kazakh National Medical University, Almaty Kazakhstan
2 City Clinical Infectious Diseases Hospital named after I.Zhekenova, Almaty, Kazakhstan
3 Department of Infectious and Tropical Diseases, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
* Corresponding Author
J CLIN MED KAZ, Volume 19, Issue 6, pp. 83-88. https://doi.org/10.23950/jcmk/12719
OPEN ACCESS 623 Views 486 Downloads
Download Full Text (PDF)

ABSTRACT

Objective: To investigate the prevalence of diabetes mellitus in comorbidity structures and its effect on the clinical course in hospitalized COVID-19 patients in south region of Kazakhstan.
Material and methods: A retrospective analysis of data from 918 patients with COVID-19 treated at the City Clinical Infectious Diseases Hospital was carried out. Pearson's Chi-square test and Student's t-test were conducted.
Results: In Kazakhstan, diabetes mellitus occupies the second position in the structure of comorbidities in patients with COVID-19 with a share of 20%. Diabetes mellitus in patients most often occurs in combination with cardiovascular diseases and arterial hypertension (20.3% and 16.3%, respectively). Combination of diabetes mellitus, arterial hypertension and other diseases was detected in 72.4% of patients. Combination of diabetes mellitus, cardiovascular and other diseases was detected in 32.5%.
In diabetes mellitus patients, COVID-19 was more severe, the hospital stay was longer, and patients over 60 years of age suffered. These patients had a combination of diabetes mellitus with arterial hypertension, obesity, and cardiovascular diseases. Hyperglycemia, elevated blood pressure, rapid breathing, and low saturation were more common for these patients.
Conclusion: Diabetes mellitus ranks second in the structure of comorbidities in COVID-19 in the south region of Kazakhstan and is characterized by a combination with cardiovascular diseases, arterial hypertension and obesity. In patients with diabetes, COVID-19 is more severe, which affects the length of stay in the hospital, the mortality rate and the need for transfer to the Intensive Care Unit.
Keywords: Pandemic, COVID-19, diabetes mellitus, comorbidities

CITATION

Abilbayeva A, Tarabayeva A, Idrisova G, Abdrakhmanova A, Sadykova A, Yegemberdiyeva R, et al. Clinical and laboratory COVID-19 features in hospitalized patients with concomitant diabetes mellitus type 2: A retrospective study. J CLIN MED KAZ. 2022;19(6):83-8. https://doi.org/10.23950/jcmk/12719

REFERENCES

  • WHO WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020.URL: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (date of the application: 01.09.2022)
  • OUR world in data. URL: https://ourworldindata.org (date of the application: 01.09.2022)
  • Zhalmagambetov B., Madikenova M., Paizullayeva S., Abbay A., Gaipov A. COVID-19 Outbreak in Kazakhstan: Current Status and Challenges. JCMK. 2020;1(55):6-8. https://doi.org/10.23950/1812-2892-JCMK-00763
  • Gaipov A., Gusmanov A., Abbay A., Sakko Y., Issanov A. et al. SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and post-hospital mortality. BMC Infectious Diseases. 2021; 21:458. https://doi.org/10.1186/s12879-021-06154-z
  • Baradaran A., Ebrahimzadeh M.H., Baradaran A., Kachooei A.R. Prevalence of Comorbidities in COVID-19 Patients: A systematic review and meta-analysis.Arch Bone Jt Surg. 2020;8:247-255. https://doi.org/10.22038/abjs.2020.47754.2346
  • Thakur B., Dubey P., Benitez J., Torres J.P., Reddy S. et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19.Scientific Reports. 2021;11:1-13. https://doi.org/10.1038/s41598-021-88130-w
  • Pya Y., Bekbossynova M., Gaipov A., Lesbekov T., Kapyshev T. et al. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan. PLOSONE. 2021. https://doi.org/10.1371/journal.pone.0261272
  • Nandy K., Salunke A., Pathak S.K., Pandey A. et al. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020; 14(5):1017-1025. https://doi.org/10.1016/j.dsx.2020.06.064
  • Unnikrishnan R., Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes.2021;11(1):21-26. https://doi.org/10.1038/s41387-021-00163-2
  • Varikasuvu S.R., Dutt N., Thangappazham B., Varshney S. Diabetes and COVID-19: A pooled analysis related to disease severity and mortality.Prim Care Diabetes. 2021;15 (1):24-27. https://doi.org/10.1016/j.pcd.2020.08.015
  • Cyril P.L., Eelco J.P.K. COVID-19 and diabetes: understanding the interrelationship and risks for a severe course. Front Endocrinol (Lausanne). 2021;12:e649525. https://doi.org/10.3389/fendo.2021.649525
  • https://rcez.kz/ "Republican Center for Electronic Health". (Date of the application – 10.11.2022)
  • Pranata R., Lim M.A., Huang I., Raharjo S.B., Lukito A.A. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020; 21(2):e1470320320926899. https://doi.org/10.1177/1470320320926899
  • Mubarik S., Liu X., Eshak E.S., Liu K. et al. The sssociation of hypertension with the severity of and mortality from the COVID-19 in the early stage of the epidemic in Wuhan, China: A multicenter retrospective cohort study.Frontiers in medicine. 2021;8: e623608. https://doi.org/10.3389/fmed.2021.623608
  • Raymond P., Huang I., Lim M.A., Wahjoepramono E.J., July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regression. Journal of Stroke and CerebrovascularDiseases. 2020;29(8):e104949. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104949
  • Demeulemeester F., Punder K., Heijningen M., Doesburg F. Obesity as a risk factor for severe COVID-19 and complications: a review. Cells. 2021;10(4):933. https://doi.org/10.3390/cells10040933
  • Sattar N., McInnes I.B., McMurray J.J.V. Obesity is a risk factor for severe COVID-19 Infection. Circulation. 2020;142(1):4-6. https://doi.org/10.1161/CIRCULATIONAHA.120.047659
  • Makhoul E., Aklinski J.L., Miller J., Leonard C. et al. A review of COVID-19 in relation to metabolic syndrome: obesity, hypertension, diabetes, and dyslipidemia. Cureus. 2022;14(7):e27438. https://doi.org/10.7759/cureus.27438
  • Wu S., Zhou K., Misra-Hebert A., Bena J., Kashyap S.R. Impact of metabolic syndrome on severity of COVID-19 illness. Metab Syndr Relat Disord. 2022;20(4):191-198. https://doi.org/10.1089/met.2021.0102
  • Zhou Y., Chi J., Lv W., Wang Y. Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19). Diabetes Metab Res Rev. 2021;37(2):e3377. https://doi.org/10.1002/dmrr.3377
  • Shi Q., Zhang X., Jiang F., Zhang X. et al. Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: A two-center, retrospective study. Diabetes Care. 2020;43(7):1382–1391. https://doi.org/10.2337/dc20-0598
  • Conway J., Gould A., Westley R., Raju S.A. et al. Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report. Diabetes Research and Clinical Practice. 2020;169:e108460. https://doi.org/10.1016/j.diabres.2020.108460
  • Angelidi A.M., Belanger M.J., Mantzoros C.S. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next. Metab Clin Exp. 2020;107:e154245. https://doi.org/10.1016/j.metabol.2020.154245
  • Kumar A., Arora A., Sharma P., Anikhindi S.A. et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14(4):535–545. https://doi.org/10.1016/j.dsx.2020.04.044
  • Kulcsar K.A., Coleman C.M., Beck S.E., Frieman M.B. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 2019;4(20):e131774. https://doi.org/10.1172/jci.insight.131774
  • Wang A., Zhao W., Xu Z., Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020;162:e108118. https://doi.org/10.1016/j.diabres.2020.108118
  • Michalakis K., Ilias I. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Diabetes Metab Syndr. 2020;14(4):469-471. https://doi.org/10.1016/j.dsx.2020.04.033
  • Albulescu R., Dima S.O., Florea I.R., Lixandru D. et al. COVID‑19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review). Experimental and Therapeutic Medicine. 2020;20(6):194. https://doi.org/10.3892/etm.2020.9324
  • Strain W.D., Hope S.V., Green A. et al. Type 2 diabetes mellitus in older people: a brief statement of key principles of modern day management including the assessment of frailty. A national collaborative stakeholder initiative. Diabet Med. 2018;35(7):838-845. https://doi.org/10.1111/dme.13644
  • Muniyappa R., Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020;318:E736–E741. https://doi.org/10.1152/ajpendo.00124.2020
  • Hussain A., Bhowmik B., Moreira N.C.V. COVID-19 and diabetes: Knowledge in progress. Diabetes Research and Clinical Practice. 2020;162:e108142. https://doi.org/10.1016/j.diabres.2020.108142